{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:56:11Z","timestamp":1778540171235,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10787-018-0475-z","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T14:39:45Z","timestamp":1524667185000},"page":"737-745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A phase I\/II randomized, controlled, clinical trial for assessment of the efficacy and safety of \u03b2-d-mannuronic acid in rheumatoid arthritis patients"],"prefix":"10.1007","volume":"26","author":[{"given":"Hossein","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Reza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Gharibdoost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noushin","family":"Rastkari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayan","family":"Mostafaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Javad","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Vojdanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd H. A.","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Aghazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Shahabeddin","family":"Mortazavi-Jahromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Mirshafiey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol 62:2569\u20132581","journal-title":"Arthritis Rheumatol"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/sji.12519","volume":"85","author":"S Aletaha","year":"2017","unstructured":"Aletaha S, Haddad L, Roozbehkia M, Bigdeli R, Asgary V, Mahmoudi M, Mirshafiey A (2017) M2000 (\u03b2-d-mannuronic acid) as a novel antagonist for blocking the TLR2 and TLR4 downstream signalling pathway. Scand J Immunol 85:122\u2013129","journal-title":"Scand J Immunol"},{"issue":"737\u2013743","key":"475_CR3","first-page":"e733","volume":"5","author":"KG Blumenthal","year":"2017","unstructured":"Blumenthal KG, Lai KH, Huang M, Wallace ZS, Wickner PG, Zhou L (2017) Adverse and hypersensitivity reactions to prescription nonsteroidal anti-inflammatory agents in a large health care system. J Allergy Clin Immunol Pract 5(737\u2013743):e733","journal-title":"J Allergy Clin Immunol Pract"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/08923973.2015.1113296","volume":"37","author":"MJ Fattahi","year":"2015","unstructured":"Fattahi MJ et al (2015) Preclinical assessment of \u03b2-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug. Immunopharmacol Immunotoxicol 37:535\u2013540","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/art.1780360601","volume":"36","author":"DT Felson","year":"1993","unstructured":"Felson DT et al (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheumatol 36:729\u2013740","journal-title":"Arthritis Rheumatol"},{"key":"475_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/art.1780380602","volume":"38","author":"DT Felson","year":"1995","unstructured":"Felson DT et al (1995) American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheumatol 38:727\u2013735","journal-title":"Arthritis Rheumatol"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46:183\u2013196","journal-title":"Immunity"},{"key":"475_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/rheumatology\/ket414","volume":"53","author":"DE Furst","year":"2014","unstructured":"Furst DE, Emery P (2014) Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology 53:1560\u20131569","journal-title":"Rheumatology"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tips.2017.05.008","volume":"38","author":"T Grosser","year":"2017","unstructured":"Grosser T, Ricciotti E, FitzGerald GA (2017) The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci 38:733\u2013748","journal-title":"Trends Pharmacol Sci"},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.18433\/J3VW2F","volume":"16","author":"S Harirforoosh","year":"2014","unstructured":"Harirforoosh S, Asghar W, Jamali F (2014) Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci 16:821\u2013847","journal-title":"J Pharm Pharm Sci"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/cam4.1013","volume":"6","author":"F Hosseini","year":"2017","unstructured":"Hosseini F et al (2017a) Targeting of crosstalk between tumor and tumor microenvironment by \u03b2-d mannuronic acid (M2000) in murine breast cancer model. Cancer Med 6:640\u2013650","journal-title":"Cancer Med"},{"key":"475_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1515\/jbcpp-2016-0092","volume":"28","author":"S Hosseini","year":"2017","unstructured":"Hosseini S et al (2017b) Anti-aging effects of M2000 (\u03b2-d-mannuronic acid) as a novel immunosuppressive drug on the enzymatic and non-enzymatic oxidative stress parameters in an experimental model. J Basic Clin Physiol Pharmacol 28:249\u2013255","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"475_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","volume":"37","author":"KY Lee","year":"2012","unstructured":"Lee KY, Mooney DJ (2012) Alginate: properties and biomedical applications. Prog Polym Sci 37:106\u2013126","journal-title":"Prog Polym Sci"},{"key":"475_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3346\/jkms.2011.26.4.561","volume":"26","author":"S-H Lee","year":"2011","unstructured":"Lee S-H, Han C-D, Yang I-H, Ha C-W (2011) Prescription pattern of NSAIDs and the prevalence of NSAID-induced gastrointestinal risk factors of orthopaedic patients in clinical practice in Korea. J Korean Med Sci 26:561\u2013567","journal-title":"J Korean Med Sci"},{"key":"475_CR15","first-page":"PI53","volume":"11","author":"A Mirshafiey","year":"2005","unstructured":"Mirshafiey A, Cuzzocrea S, Rehm B, Matsuo H (2005a) M2000: a revolution in pharmacology. Med Sci Monit 11:PI53\u2013PI63","journal-title":"Med Sci Monit"},{"key":"475_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-3083.2005.01594.x","volume":"61","author":"A Mirshafiey","year":"2005","unstructured":"Mirshafiey A, Cuzzocrea S, Rehm B, Mazzon E, Saadat F, Sotoude M (2005b) Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug. Scand J Immunol 61:435\u2013441","journal-title":"Scand J Immunol"},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1081\/IPH-200067751","volume":"27","author":"A Mirshafiey","year":"2005","unstructured":"Mirshafiey A, Matsuo H, Nakane S, Rehm BH, Koh C-S, Miyoshi S (2005c) Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis. Immunopharmacol Immunotoxicol 27:255\u2013265","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"475_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.etap.2007.02.002","volume":"24","author":"A Mirshafiey","year":"2007","unstructured":"Mirshafiey A, Rehm B, Abhari RS, Borzooy Z, Sotoude M, Razavi A (2007a) Production of M2000 (\u03b2-d-mannuronic acid) and its therapeutic effect on experimental nephritis. Environ Toxicol Pharmacol 24:60\u201366","journal-title":"Environ Toxicol Pharmacol"},{"key":"475_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/08923970701282387","volume":"29","author":"A Mirshafiey","year":"2007","unstructured":"Mirshafiey A, Rehm B, Sotoude M, Razavi A, Abhari RS, Borzooy Z (2007b) Therapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritis. Immunopharmacol Immunotoxicol 29:49\u201361","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"475_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.pharep.2017.04.015","volume":"69","author":"A Mirshafiey","year":"2017","unstructured":"Mirshafiey A et al (2017) Introduction of \u03b2-d-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1\/COX-2 activity and gene expression. Pharmacol Rep 69:1067\u20131072","journal-title":"Pharmacol Rep"},{"key":"475_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/acr.22811","volume":"68","author":"M Movahedi","year":"2016","unstructured":"Movahedi M, Beauchamp ME, Abrahamowicz M, Ray DW, Michaud K, Pedro S, Dixon WG (2016) Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis. Arthritis Rheumatol 68:1089\u20131098","journal-title":"Arthritis Rheumatol"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/art.1780261107","volume":"26","author":"T Pincus","year":"1983","unstructured":"Pincus T, Summey JA, Soraci SA, Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheumatol 26:1346\u20131353","journal-title":"Arthritis Rheumatol"},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"M Prevoo","year":"1995","unstructured":"Prevoo M, Van\u2019T Hof MA, Kuper H, Van Leeuwen M, Van De Putte L, Van Riel P (1995) Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheumatol 38:44\u201348","journal-title":"Arthritis Rheumatol"},{"key":"475_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","volume":"24","author":"C Sostres","year":"2010","unstructured":"Sostres C, Gargallo CJ, Arroyo MT, Lanas A (2010) Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 24:121\u2013132","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"475_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00296-016-3649-2","volume":"37","author":"Y-K Sung","year":"2017","unstructured":"Sung Y-K et al (2017) Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis. Rheumatol Int 37:975\u2013982","journal-title":"Rheumatol Int"},{"key":"475_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.carbpol.2017.01.041","volume":"166","author":"L Youssouf","year":"2017","unstructured":"Youssouf L et al (2017) Ultrasound-assisted extraction and structural characterization by NMR of alginates and carrageenans from seaweeds. Carbohydr Polym 166:55\u201363","journal-title":"Carbohydr Polym"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-018-0475-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0475-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0475-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T23:27:45Z","timestamp":1556148465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-018-0475-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,25]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s10787-018-0475-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,25]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}